US 12,145,916 B2
Polymorph form of pitolisant hydrochloride
Marc Capet, Melesse (FR); and Morgan Pauchet, Mont Saint Aignan (FR)
Assigned to Bioprojet PHARMA, Paris (FR)
Filed by Bioprojet PHARMA, Paris (FR)
Filed on Mar. 29, 2024, as Appl. No. 18/621,972.
Claims priority of provisional application 63/493,500, filed on Mar. 31, 2023.
Prior Publication US 2024/0327366 A1, Oct. 3, 2024
Int. Cl. C07D 295/088 (2006.01); A61K 31/4453 (2006.01)
CPC C07D 295/088 (2013.01) [A61K 31/4453 (2013.01)] 15 Claims
 
1. A crystalline form of a compound represented by Formula (I):

OG Complex Work Unit Chemistry
characterized by having an X-ray diffraction pattern comprising each of the following peaks, in terms of 2-theta (2θ): 16.8°, 18.2°, 18.5°, 21.1°, and 25.1° (±) 0.2°.